The Food and Drug Administration has approved a generic version of the abortion pill mifepristone, expanding its supply at a time when the Trump administration is under pressure from abortion opponents to sharply restrict access to abortion pills.

The approval, issued Tuesday without a public announcement, means that three American companies can now produce mifepristone for abortion. The FDA approved the original pill 25 years ago, and in 2019, it approved the first generic version.

The decision comes as anti-abortion activists have been urging the FDA and the Department of Health and Human Services to curtail access to abortion pills. They have been prescribed in increasing numbers in the years since the Supreme Court overturned the national right to abortion in 2022.

Currently, nearly

See Full Page